Comparing Lipinskis Rule of 5 and Machine Learning Based Prediction of Fraction Absorbed for Assessing Oral Absorption in Humans
Fagerholm, U.; Hellberg, S.; Alvarsson, J.; Ekmefjord, M.; Spjuth, O.
Show abstract
BackgroundThe influential Lipinskis Rule of 5 (Ro5) describes molecular properties important for oral absorption in humans. According to Ro5, poor absorption is more likely when 2 or more of its criteria (molecular weight (MW) >500 g/mol, calculated octanol-water partition coefficient (clog P) >5, >5 hydrogen bond donors (HBD) and >10 hydrogen bond acceptors (HBA)) are violated. Earlier evaluations have shown that many drugs are sufficiently well absorbed into the systemic circulation despite many Ro5-violations. No evaluation of Ro5 vs fraction absorbed (fa) has, however, been done. MethodsDatasets of orally administered drugs violating and not violating Ro5 and with available human clinical fa-values were assembled, and contrasted to machine learning based predictions using the ANDROMEDA prediction software having a major MW-domain of 150-750 g/mol. Results129 Ro5-violent compounds (29 with MW>1000 g/mol) were found, 59 of which had fa-values (42 % mean fa). 34 % and 66 % of compounds were predicted as having fa[≤]10% and >10-30 % respectively, which was in good agreement with measured fa of 37 % and 63 %. The fa for all compounds with fa[≤]5 and [≤]10 % were correctly predicted. For compounds with fa>30 %, 81 % were predicted to have a fa>30 %, but none were predicted to have a fa<10 %. The Q2 for predicted vs observed fa was 0.64. For a set of 77 compounds without Ro5 violation (80 % mean fa), all compounds were correctly predicted to have a fa below or above 30 % (Q2=0.56). Among these are compounds with poor uptake (<1 % to 7 %). ConclusionWe show that machine learning based predictions of fa are superior to Ro5 for assessing oral absorption obstacles in humans. Too strict reliance on Ro5 may hence constitute a risk. ANDROMEDA predicts fa well, easily and quickly, and also differentiates well between poor and adequate oral uptake for compounds violating and not-violating Ro5. This makes it a valid and useful tool capable of predicting oral absorption in humans with good accuracy and replacing Ro5 for oral absorption assessments.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- PBPK modelling of dexamethasone in patients with COVID-19 and liver disease 95%
- Innovative, rapid, high throughput method for drug repurposing in a pandemic - a case study of SARS-CoV-2 and COVID-19 94%
- Physiologically based pharmacokinetic (PBPK) modeling of the role of CYP2D6 polymorphism for metabolic phenotyping with dextromethorphan 94%
Similar papers in this journal
- Clinical safety and pharmacokinetics of a novel oral niclosamide formulation compared with marketed niclosamide chewing tablets in healthy volunteers: a three-part randomized, double-blind, placebo-controlled trial 95%
- DigiLoCS: A Leap Forward in Predictive Organ-on-Chip Simulations 94%
- Effects of a rifampicin pre-treatment on linezolid pharmacokinetics 93%
Similar papers in this journal
- Interactions of anti-COVID-19 drug candidates with multispecific ABC and OATP drug transporters 94%
- Improved bioavailability of montelukast through a novel oral mucoadhesive film in humans and mice 94%
- Amorphous solid dispersions and the confounding effect of nanoparticles in in vitro dissolution and in vivo testing: Niclosamide as a case of study 91%
Similar papers in this journal
- Pharmacokinetic modelling to estimate intracellular favipiravir ribofuranosyl-5’-triphosphate exposure to support posology for SARS-CoV-2 94%
- Optimal dosing of cefotaxime and desacetylcefotaxime for critically ill paediatric patients. Can we use microsampling? 93%
- Seeking an optimal dosing regimen for OZ439-DSM265 combination therapy for treating uncomplicated falciparum malaria 91%
Similar papers in this journal
- Predicting the Disposition of the Antimalarial Drug Artesunate and its Active Metabolite Dihydroartemisinin Using Physiologically-Based Pharmacokinetic Modeling 93%
- Human Safety, Tolerability, and Pharmacokinetics of a Novel Broad-Spectrum Oral Antiviral Compound, Molnupiravir, with Activity Against SARS-CoV-2 92%
- Pharmacokinetics and safety of XAV-19, a swine glyco-humanized polyclonal anti-SARS-CoV-2 antibody, for COVID-19-related moderate pneumonia: a randomized, double-blind, placebo-controlled, phase IIa study 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.